DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/tb6rxz/biotechnology) has announced the addition of the "Biotechnology Companies in Emerging Markets (China, Singapore, Brazil, South Africa, South Korea, Turkey, India, Russia)" report to their offering.
What's happening in biotechnology in the fastest-growing economies of the world?
Who are the leaders operating in these nations and what partnerships have they completed?
This report provides answers and informs readers of the companies they need to know about. Companies seeking new partners, companies to invest in or firms benchmarking competition will want to purchase this resource of today's biotech market in the countries outside the United States and Europe.
The report identifies eight important emerging company markets and details the biotech market size in these markets. Biotechnology is one of the fastest-growing segments of the world economy. By the year 2025 it has been estimated that the world biotechnology market will reach $2 trillion. By developing biotech, countries lay the groundwork for their own long-term economic growth.
In recent years, investment in U.S. biotech research has been reduced by billions of dollars while at the same time investment in such research in emerging markets has dramatically increased. As a result of this investment, many of these emerging market countries have put in place formal strategies to capitalize on the opportunities such expenditures represent.
Key Topics Covered:
ONE: EXECUTIVE SUMMARY
Introduction
Methodology
TWO: BIOTECHNOLOGY IN EMERGING MARKETS
Introduction
Selected Emerging Markets
China
Singapore
Brazil
South Africa
South Korea
Turkey
India
Russia
Recent Deals, Partnerships, and Strategic Alliances
For more information visit http://www.researchandmarkets.com/research/tb6rxz/biotechnology
